Immunotherapy utilization for hepatobiliary cancer in the United States: disparities among patients with different socioeconomic status

BACKGROUND: Patients with advanced hepatobiliary cancer (HBC) have a dismal prognosis and limited treatment options. Immunotherapy has been considered as a promising treatment, especially for cancers not amenable to surgery. METHODS: Between 2004, and 2015, patients diagnosed with hepatocellular car...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hepatobiliary Surg Nutr
Autors principals: Sahara, Kota, Farooq, S. Ayesha, Tsilimigras, Diamantis I., Merath, Katiuscha, Paredes, Anghela Z., Wu, Lu, Mehta, Rittal, Hyer, J. Madison, Endo, Itaru, Pawlik, Timothy M.
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2020
Matèries:
Original Article on Colorectal Cancer Liver Metastasis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7026778/
https://ncbi.nlm.nih.gov/pubmed/32140475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/hbsn.2019.07.01
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars